Announcements Trials
Browse Landscape

Phase

Phase 1 12Phase 1/2 8Phase NA 7Phase 2 3Phase 3 2Phase EARLY_PHASE1 1Phase 4 1Phase 2/3 1

Status

Completed 36Recruiting 23Unknown 19Terminated 10Not yet recruiting 7Active not recruiting 4Withdrawn 1Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 2Rectal Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Lung Neoplasms 1Liver Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma 1Breast Neoplasms 1Breast Carcinoma In Situ 1Agnosia 1Adenocarcinoma of Lung 1

Interventions

NUC-1031 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Suspended × Neoplasms × Clear all
NCT03610100 2019-10-29

ACELARATE

The Clatterbridge Cancer Centre NHS Foundation Trust

Phase 2/3 Suspended
328 enrolled
Gastrointestinal

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡